Back to Journals » OncoTargets and Therapy » Volume 11

Real-world usage and clinical outcomes of alectinib among post-crizotinib progression anaplastic lymphoma kinase positive non-small-cell lung cancer patients in the USA

Total article views   Abstract views HTML views PDF downloads Totals
5,230 Dovepress* 3,332 1,191+ 999 4,523
PubMed Central* 0 707 175 707
Totals 3,332 1,898 1,174 5,230
*Since 22 December 2017
+Since July 2016

View citations on PubMed Central and Google Scholar